Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Solid Biosciences Inc.

    NASDAQ: SLDB · Real-Time Price · USD
    4.50
    -0.08 (-1.75%)
    At close: Jun 13, 2025, 3:59 PM
    4.50
    -0.11%
    After-hours: Jun 13, 2025, 06:54 PM EDT

    Solid Biosciences Statistics

    Share Statistics

    Solid Biosciences has 77.52M shares outstanding. The number of shares has increased by 101.91% in one year.

    Shares Outstanding

    n/a
    		 77.52M

    Shares Change (YoY)

    n/a
    		 101.91%

    Shares Change (QoQ)

    n/a
    		 93.95%

    Owned by Institutions (%)

    n/a
    		 89.01%

    Shares Floating

    n/a
    		 56.28M

    Failed to Deliver (FTD) Shares

    n/a
    		 12,172

    FTD / Avg. Volume

    n/a
    		 0.74%

    Short Selling Information

    The latest short interest is 8.35M, so 10.77% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.35M

    Short % of Shares Out

    n/a
    		 10.77%

    Short % of Float

    n/a
    		 12.81%

    Short Ratio (days to cover)

    n/a
    		 5.33

    Valuation Ratios

    The PE ratio is -1.31 and the forward PE ratio is -2.14. Solid Biosciences's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.31

    Forward PE

    n/a
    		 -2.14

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 1.19

    P/FCF Ratio

    n/a
    		 -1.62

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Solid Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.2, with a Debt / Equity ratio of 0.18.

    Current Ratio

    n/a
    		 5.2

    Quick Ratio

    n/a
    		 5.2

    Debt / Equity

    n/a
    		 0.18

    Debt / EBITDA

    n/a
    		 -0.2

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 -381.55

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,246,970

    Employee Count

    n/a
    		 100

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -43.04% in the last 52 weeks. The beta is 2.22, so Solid Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.22

    52-Week Price Change

    n/a
    		 -43.04%

    50-Day Moving Average

    n/a
    		 3.29

    200-Day Moving Average

    n/a
    		 4.85

    Relative Strength Index (RSI)

    n/a
    		 65.19

    Average Volume (20 Days)

    n/a
    		 1,648,917

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -2.46M

    Operating Income

    n/a
    		 -129.73M

    Net Income

    n/a
    		 -124.7M

    EBITDA

    n/a
    		 -121.9M

    EBIT

    n/a
    		 -125.04M

    Earnings Per Share (EPS)

    n/a
    		 -3.06
    Full Income Statement

    Balance Sheet

    The company has 80.23M in cash and 24.18M in debt, giving a net cash position of 56.06M.

    Cash & Cash Equivalents

    n/a
    		 80.23M

    Total Debt

    n/a
    		 24.18M

    Net Cash

    n/a
    		 56.06M

    Retained Earnings

    n/a
    		 -783.45M

    Total Assets

    n/a
    		 343.9M

    Working Capital

    n/a
    		 284.63M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -100.01M and capital expenditures -654K, giving a free cash flow of -100.67M.

    Operating Cash Flow

    n/a
    		 -100.01M

    Capital Expenditures

    n/a
    		 -654K

    Free Cash Flow

    n/a
    		 -100.67M

    FCF Per Share

    n/a
    		 -2.47
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SLDB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SLDB is $15, which is 233.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 233.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 28, 2022. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Oct 28, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -0.63

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist